Literature DB >> 22990108

Single nucleotide polymorphisms of genes for EGF, TGF-β and TNF-α in patients with pancreatic carcinoma.

Lei Zhang1, Guoyang Wu, Florian Herrle, Marco Niedergethmann, Michael Keese.   

Abstract

AIM: To show whether single nucleotide polymorphisms (SNPs) of Epidermal growth factor (EGF)-61(*)A/G, Transforming growth factor beta 1 (TGF-B1) - 509(*)T/C and Tumor necrosis factor-alpha (TNF-A) -308(*)A/G are associated with the survival rate after pancreatic cancer surgery and with the frequency of post-operative complications. PATIENTS AND METHODS: EGF 61(*)A/G, TGF-B1-509(*)T/C and TNF-A-308(*)A/G genotypes were analyzed in patients who underwent pylorus-preserving pancreaticoduonectomy for pancreatic carcinoma and were determined by means of Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP). The association of each genetic polymorphism with clinical and pathological data of the patients and early tumor recurrence were evaluated.
RESULTS: A significantly lower median survival duration was found in EGF 61(*)AA homozygotes, as compared to the AG heterozygous group. There was also a significantly lower median survival duration in the TNF-A-308(*) AA homozygote group as compared to the AG and GG groups. Survival duration in patients had no correlation with TGF-B1 -509(*)T/C polymorphism. There was a significantly lower median survival duration in the TNF-A -308(*) AA homozygous group, as compared to the AG and GG group in a Cox proportional hazard model. The frequency of the TGF-B1 T-allele was higher among patients with leakage of the pancreatic anastomosis. The frequency of the TGF-B1 TC genotype was significantly higher among patients who developed leakage of the biliodigestive anastomosis as compared with the TGF-B1 CC genotype. The frequency of TGF-B1 T-carriers (i.e. TT+TC) was significantly higher among patients with leakage of the biliodigestive anastomosis, as compared to these with the TGF-B1 CC genotype. In a Cox proportional hazard model, only wound infection had a significant correlation with long-term survival duration of patients with pancreatic cancer.
CONCLUSION: There appears to be a significant correlation of the EGF-61(*) AA and of the TNF-A -308(*) AA polymorphism with lower survival duration in patients with resectable pancreatic carcinoma. The presence of wound infection was associated with poor prognosis. TGF-B1-509(*) T-carrying genotypes were more frequent in paitents with severe post-operative complications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22990108

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  9 in total

1.  Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy.

Authors:  Caiyun Zhang; Erich M Sturgis; Hongliang Zheng; Xicheng Song; Peng Wei; Lei Jin; Li Chao; Qingyi Wei; Guojun Li
Journal:  Int J Cancer       Date:  2013-10-24       Impact factor: 7.396

2.  TNF-α promoter polymorphisms and risk of recurrence in patients with squamous cell carcinomas of the nonoropharynx.

Authors:  Caiyun Zhang; Erich M Sturgis; Hongliang Zheng; Mark E Zafereo; Qingyi Wei; Guojun Li
Journal:  Int J Cancer       Date:  2014-02-27       Impact factor: 7.396

3.  Overexpressing TNF-alpha in pancreatic ductal adenocarcinoma cells and fibroblasts modifies cell survival and reduces fatty acid synthesis via downregulation of sterol regulatory element binding protein-1 and activation of acetyl CoA carboxylase.

Authors:  Mazhar Al-Zoubi; Galina Chipitsyna; Shivam Saxena; Konrad Sarosiek; Ankit Gandhi; Christopher Y Kang; Daniel Relles; Jocelyn Andrelsendecki; Terry Hyslop; Charles J Yeo; Hwyda A Arafat
Journal:  J Gastrointest Surg       Date:  2013-10-04       Impact factor: 3.452

4.  Positive association between lymphotoxin-alpha variation rs909253 and cancer risk: a meta-analysis based on 36 case-control studies.

Authors:  Xi Yu; Yi Huang; Changhong Li; Hailian Yang; Caide Lu; Shiwei Duan
Journal:  Tumour Biol       Date:  2013-10-18

5.  Determination of VEGFR-2 (KDR) 604A>G Polymorphism in Pancreatic Disorders.

Authors:  Vlad Pădureanu; Mihail Virgil Boldeanu; Ioana Streaţă; Mihai Gabriel Cucu; Isabela Siloşi; Lidia Boldeanu; Maria Bogdan; Anca Ştefania Enescu; Maria Forţofoiu; Aurelia Enescu; Elena Mădălina Dumitrescu; Dragoş Alexandru; Valeriu Marian Şurlin; Mircea Cătălin Forţofoiu; Ileana Octavia Petrescu; Florin Petrescu; Mihai Ioana; Marius Eugen Ciurea; Adrian Săftoiu
Journal:  Int J Mol Sci       Date:  2017-02-17       Impact factor: 5.923

6.  TGF-β1 polymorphisms -509 C>T and +915 G>C and risk of pancreatic cancer.

Authors:  Faegheh Behboudi Farahbakhsh; Ehsan Nazemalhosseini Mojarad; Pedram Azimzadeh; Faezeh Goudarzi; Amir Houshang Mohammad Alizadeh; Mehrdad Haghazali; Reza Mahmoudi Lamoki; Hamid Asadzadeh Aghdaei
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017

7.  NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma.

Authors:  Donnele Daley; Vishnu R Mani; Navyatha Mohan; Neha Akkad; Gautam S D Balasubramania Pandian; Shivraj Savadkar; Ki Buom Lee; Alejandro Torres-Hernandez; Berk Aykut; Brian Diskin; Wei Wang; Mohammad S Farooq; Arif I Mahmud; Gregor Werba; Eduardo J Morales; Sarah Lall; Benjamin J Wadowski; Amanda G Rubin; Matthew E Berman; Rajkishen Narayanan; Mautin Hundeyin; George Miller
Journal:  J Exp Med       Date:  2017-04-25       Impact factor: 14.307

8.  The Role of Fibroblasts in Pancreatic Cancer: Extracellular Matrix Versus Paracrine Factors.

Authors:  Louisa Bolm; Simon Cigolla; Uwe A Wittel; Ulrich T Hopt; Tobias Keck; Dirk Rades; Peter Bronsert; Ulrich Friedrich Wellner
Journal:  Transl Oncol       Date:  2017-06-26       Impact factor: 4.243

9.  Association Between Functional Nucleotide Polymorphisms Up-regulating Transforming Growth Factor β1 Expression and Increased Tuberculosis Susceptibility.

Authors:  Su Zhang; Guobao Li; Jing Bi; Qinglong Guo; Xiangdong Fu; Wenfei Wang; Shuyan Liu; Guohui Xiao; Min Ou; Juanjuan Zhang; Xing He; Fang Li; Guanqiang Li; Carl G Feng; Xinchun Chen; Guoliang Zhang
Journal:  J Infect Dis       Date:  2022-03-02       Impact factor: 5.226

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.